Another cross-sectional study that enrolled elderly in-patients with type 2 diabetes who received insulin therapy showed that daytime and pre-midnight mean glucose levels were reliable markers to identify patients with an increased risk of nocturnal hypoglycemia [18]. The gene discussed is INS; the disease is Hypoglycemia.